Idiopathic pulmonary fibrosis (IPF) is a clinical syndrome of unknown cause affecting primarily middle aged or elderly patients. IPF follows an inexorably progressive and, usually, fatal course. It is associated with the histopathological pattern of usual interstitial pneumonia on surgical lung biopsy (...
Idiopathic Pulmonary Fibrosis (IPF) is a chronic lung disease that develops when the lung tissue becomes scared or fibrotic over time. The scarring progresses differently in everyone, as some people’s disease stays the same for years, and in others, the condition can worsen rapidly. ...
Idiopathic Pulmonary FibrosisInterstitial Lung DiseasePharmacotherapyObjectives To discuss the pathophysiological hypotheses of IPF with a view to summarize the data on pharmacological aspects of treatment of this fibrotic Interstitial Lung Disease. Furthermore, the adverse effects are briefly discussed for the...
Idiopathic pulmonary fibrosis (IPF) is a serious lung disease. When you breathe in, oxygen moves through tiny air sacs in your lungs and into your bloodstream. From there, it travels to your organs. IPF causes scar tissue to grow inside your lungs and makes it hard to breathe. It gets w...
Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive interstitial lung disease. IPF is more common in elderly patients and over time as healthy lung tissue is replaced by altered extracellular matrix (fibrosis) the alveolar architecture is destroyed, leading to decreased lung function and fin...
Fibrosis, or scar tissue, develops and prevents the lungs from working normally. This gradually interferes with a person’s ability to breathe and function. IPF belongs to a family of more than 100 related diseases, called interstitial lung diseases (ILDs), which often have similar characteristics...
Idiopathic pulmonary fibrosis (IPF) is a chronic interstitial lung disease of unknown etiology, characterized by progressive lung scarring. Global incidence and prevalence of IPF range between 0.09 and 1.30 per 10,000 people, and it affects more than 3 million people worldwide. Patients are ...
Idiopathic pulmonary fibrosis (IPF) is the most common and most deadly type of interstitial lung disease. It is fatal and progressive, characterized by scarring and damage of lung tissue next to the alveoli. This process causes an irreversible loss of the tissue’s ability to exchange oxygen, ...
Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive lung disease characterized by progressive lung scarring and the histological picture of usual interstitial pneumonia (UIP). It is associated with increasing cough and dyspnoea and impaired quality of life. IPF affects ∼3 million people ...
Idiopathic pulmonary fibrosis (IPF), also called interstitial pneumonia or fibrosing alveolitis, is a progressive interstitial lung disease of unknown origin. Two distinct forms are known which differ in course, morphologic features and cytological findings in bronchoalveolar lavage: a cellular "desquamat...